House Leaders Seek GAO Review Of Possible “Anticipatory Price Gouging” By Drug Firms (The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
AstraZeneca’s Brilinta filed in the USA (PharmaTimes.com)
US regulator wants more information on Rituxan for CLL (PharmaTimes.com)
Amgen bags awards for best pipeline and for Nplate (PharmaTimes.com)
Enhance beauty at a discount (DetNews.com)
Preeclampsia Tied to Future Thyroid Issues (MedPage Today)
Levels Of Bad Cholesterol Falling In US, But Still Too Many Unscreened And Untreated (Medical News Today)
FDA panel gives backing to Pfizer’s Prevnar 13 (PharmaTimes.com)
SUBSCRIBE